Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
Testing the impaired disengagement hypothesis: The role of attentional control and positive metacognitive beliefs in depression.

Behaviour research and therapy

Salguero JM, Ramos-Cejudo J, García-Sancho E, Arbulu I, Zaccagnini JL, Bjureberg J, Gross JJ.
PMID: 34543923
Behav Res Ther. 2021 Nov;146:103961. doi: 10.1016/j.brat.2021.103961. Epub 2021 Sep 08.

The impaired disengagement hypothesis holds that people ruminate - and thus increase their risk for depression - due to impaired attentional control and conflict signaling. We tested this hypothesis by examining the role of attentional control and conflict signaling...

Cite
Salguero JM, Ramos-Cejudo J, García-Sancho E, et al. Testing the impaired disengagement hypothesis: The role of attentional control and positive metacognitive beliefs in depression. Behav Res Ther. 2021;146:103961doi: 10.1016/j.brat.2021.103961.
Salguero, J. M., Ramos-Cejudo, J., García-Sancho, E., Arbulu, I., Zaccagnini, J. L., Bjureberg, J., & Gross, J. J. (2021). Testing the impaired disengagement hypothesis: The role of attentional control and positive metacognitive beliefs in depression. Behaviour research and therapy, 146103961. https://doi.org/10.1016/j.brat.2021.103961
Salguero, José M, et al. "Testing the impaired disengagement hypothesis: The role of attentional control and positive metacognitive beliefs in depression." Behaviour research and therapy vol. 146 (2021): 103961. doi: https://doi.org/10.1016/j.brat.2021.103961
Salguero JM, Ramos-Cejudo J, García-Sancho E, Arbulu I, Zaccagnini JL, Bjureberg J, Gross JJ. Testing the impaired disengagement hypothesis: The role of attentional control and positive metacognitive beliefs in depression. Behav Res Ther. 2021 Nov;146:103961. doi: 10.1016/j.brat.2021.103961. Epub 2021 Sep 08. PMID: 34543923.
Copy Download .nbib Format: NLM
The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study.

Frontiers in aging neuroscience

Ramos-Cejudo J, Johnson AD, Beiser A, Seshadri S, Salinas J, Berger JS, Fillmore NR, Do N, Zheng C, Kovbasyuk Z, Ardekani BA, Bubu OM, Parekh A, Convit A, Betensky RA, Wisniewski TM, Osorio RS.
PMID: 34916927
Front Aging Neurosci. 2021 Nov 30;13:773984. doi: 10.3389/fnagi.2021.773984. eCollection 2021.

No abstract available.

Cite
Ramos-Cejudo J, Johnson AD, Beiser A, et al. The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study. Front Aging Neurosci. 2021;13:773984doi: 10.3389/fnagi.2021.773984.
Ramos-Cejudo, J., Johnson, A. D., Beiser, A., Seshadri, S., Salinas, J., Berger, J. S., Fillmore, N. R., Do, N., Zheng, C., Kovbasyuk, Z., Ardekani, B. A., Bubu, O. M., Parekh, A., Convit, A., Betensky, R. A., Wisniewski, T. M., & Osorio, R. S. (2021). The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study. Frontiers in aging neuroscience, 13773984. https://doi.org/10.3389/fnagi.2021.773984
Ramos-Cejudo, Jaime, et al. "The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study." Frontiers in aging neuroscience vol. 13 (2021): 773984. doi: https://doi.org/10.3389/fnagi.2021.773984
Ramos-Cejudo J, Johnson AD, Beiser A, Seshadri S, Salinas J, Berger JS, Fillmore NR, Do N, Zheng C, Kovbasyuk Z, Ardekani BA, Bubu OM, Parekh A, Convit A, Betensky RA, Wisniewski TM, Osorio RS. The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study. Front Aging Neurosci. 2021 Nov 30;13:773984. doi: 10.3389/fnagi.2021.773984. eCollection 2021. PMID: 34916927; PMCID: PMC8670436.
Copy Download .nbib Format: NLM
Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder.

Biomarkers in neuropsychiatry

Pillai A, Bruno D, Nierenberg J, Pandya C, Feng T, Reichert C, Ramos-Cejudo J, Osorio R, Zetterberg H, Blennow K, Pomara N.
PMID: 31942568
Biomark Neuropsychiatry. 2019 Dec;1. doi: 10.1016/j.bionps.2019.100007. Epub 2019 Nov 13.

Late-life major depression (LLMD) is a risk factor for the development of mild cognitive impairment and dementia, including Alzheimer's disease (AD) and vascular dementia. Immune dysregulation and changes in innate immune responses in particular, have been implicated in the...

Cite
Pillai A, Bruno D, Nierenberg J, et al. Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder. Biomark Neuropsychiatry. 2019;1doi: 10.1016/j.bionps.2019.100007.
Pillai, A., Bruno, D., Nierenberg, J., Pandya, C., Feng, T., Reichert, C., Ramos-Cejudo, J., Osorio, R., Zetterberg, H., Blennow, K., & Pomara, N. (2019). Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder. Biomarkers in neuropsychiatry, 1. https://doi.org/10.1016/j.bionps.2019.100007
Pillai, Anilkumar, et al. "Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder." Biomarkers in neuropsychiatry vol. 1 (2019). doi: https://doi.org/10.1016/j.bionps.2019.100007
Pillai A, Bruno D, Nierenberg J, Pandya C, Feng T, Reichert C, Ramos-Cejudo J, Osorio R, Zetterberg H, Blennow K, Pomara N. Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder. Biomark Neuropsychiatry. 2019 Dec;1. doi: 10.1016/j.bionps.2019.100007. Epub 2019 Nov 13. PMID: 31942568; PMCID: PMC6961956.
Copy Download .nbib Format: NLM
The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study.

Frontiers in aging neuroscience

Ramos-Cejudo J, Johnson AD, Beiser A, Seshadri S, Salinas J, Berger JS, Fillmore NR, Do N, Zheng C, Kovbasyuk Z, Ardekani BA, Bubu OM, Parekh A, Convit A, Betensky RA, Wisniewski TM, Osorio RS.
PMID: 34916927
Front Aging Neurosci. 2021 Nov 30;13:773984. doi: 10.3389/fnagi.2021.773984. eCollection 2021.

No abstract available.

Cite
Ramos-Cejudo J, Johnson AD, Beiser A, et al. The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study. Front Aging Neurosci. 2021;13:773984doi: 10.3389/fnagi.2021.773984.
Ramos-Cejudo, J., Johnson, A. D., Beiser, A., Seshadri, S., Salinas, J., Berger, J. S., Fillmore, N. R., Do, N., Zheng, C., Kovbasyuk, Z., Ardekani, B. A., Bubu, O. M., Parekh, A., Convit, A., Betensky, R. A., Wisniewski, T. M., & Osorio, R. S. (2021). The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study. Frontiers in aging neuroscience, 13773984. https://doi.org/10.3389/fnagi.2021.773984
Ramos-Cejudo, Jaime, et al. "The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study." Frontiers in aging neuroscience vol. 13 (2021): 773984. doi: https://doi.org/10.3389/fnagi.2021.773984
Ramos-Cejudo J, Johnson AD, Beiser A, Seshadri S, Salinas J, Berger JS, Fillmore NR, Do N, Zheng C, Kovbasyuk Z, Ardekani BA, Bubu OM, Parekh A, Convit A, Betensky RA, Wisniewski TM, Osorio RS. The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study. Front Aging Neurosci. 2021 Nov 30;13:773984. doi: 10.3389/fnagi.2021.773984. eCollection 2021. PMID: 34916927; PMCID: PMC8670436.
Copy Download .nbib Format: NLM
Endotyping Sleep Apnea One Breath at a Time: An Automated Approach for Separating Obstructive from Central Sleep-disordered Breathing.

American journal of respiratory and critical care medicine

Parekh A, Tolbert TM, Mooney AM, Ramos-Cejudo J, Osorio RS, Treml M, Herkenrath SD, Randerath WJ, Ayappa I, Rapoport DM.
PMID: 34449303
Am J Respir Crit Care Med. 2021 Dec 15;204(12):1452-1462. doi: 10.1164/rccm.202011-4055OC.

No abstract available.

Cite
Parekh A, Tolbert TM, Mooney AM, et al. Endotyping Sleep Apnea One Breath at a Time: An Automated Approach for Separating Obstructive from Central Sleep-disordered Breathing. Am J Respir Crit Care Med. 2021;204(12):1452-1462doi: 10.1164/rccm.202011-4055OC.
Parekh, A., Tolbert, T. M., Mooney, A. M., Ramos-Cejudo, J., Osorio, R. S., Treml, M., Herkenrath, S. D., Randerath, W. J., Ayappa, I., & Rapoport, D. M. (2021). Endotyping Sleep Apnea One Breath at a Time: An Automated Approach for Separating Obstructive from Central Sleep-disordered Breathing. American journal of respiratory and critical care medicine, 204(12), 1452-1462. https://doi.org/10.1164/rccm.202011-4055OC
Parekh, Ankit, et al. "Endotyping Sleep Apnea One Breath at a Time: An Automated Approach for Separating Obstructive from Central Sleep-disordered Breathing." American journal of respiratory and critical care medicine vol. 204,12 (2021): 1452-1462. doi: https://doi.org/10.1164/rccm.202011-4055OC
Parekh A, Tolbert TM, Mooney AM, Ramos-Cejudo J, Osorio RS, Treml M, Herkenrath SD, Randerath WJ, Ayappa I, Rapoport DM. Endotyping Sleep Apnea One Breath at a Time: An Automated Approach for Separating Obstructive from Central Sleep-disordered Breathing. Am J Respir Crit Care Med. 2021 Dec 15;204(12):1452-1462. doi: 10.1164/rccm.202011-4055OC. PMID: 34449303.
Copy Download .nbib Format: NLM
Endotyping Sleep Apnea One Breath at a Time: An Automated Approach for Separating Obstructive from Central Sleep Disordered Breathing.

American journal of respiratory and critical care medicine

Parekh A, Tolbert TM, Mooney AM, Ramos-Cejudo J, Osorio RS, Treml M, Herkenrath SD, Randerath WJ, Ayappa I, Rapoport DM.
PMID: 34449303
Am J Respir Crit Care Med. 2021 Aug 27; doi: 10.1164/rccm.202011-4055OC. Epub 2021 Aug 27.

RATIONALE: Determining whether an individual has obstructive or central sleep apnea is fundamental to selecting the appropriate treatment.OBJECTIVES: Here we derive an automated breath-by-breath probability of obstruction, as a surrogate of gold-standard upper airway resistance, using hallmarks of upper...

Cite
Parekh A, Tolbert TM, Mooney AM, et al. Endotyping Sleep Apnea One Breath at a Time: An Automated Approach for Separating Obstructive from Central Sleep Disordered Breathing. Am J Respir Crit Care Med. 2021;doi: 10.1164/rccm.202011-4055OC.
Parekh, A., Tolbert, T. M., Mooney, A. M., Ramos-Cejudo, J., Osorio, R. S., Treml, M., Herkenrath, S. D., Randerath, W. J., Ayappa, I., & Rapoport, D. M. (2021). Endotyping Sleep Apnea One Breath at a Time: An Automated Approach for Separating Obstructive from Central Sleep Disordered Breathing. American journal of respiratory and critical care medicine, . https://doi.org/10.1164/rccm.202011-4055OC
Parekh, Ankit, et al. "Endotyping Sleep Apnea One Breath at a Time: An Automated Approach for Separating Obstructive from Central Sleep Disordered Breathing." American journal of respiratory and critical care medicine vol. (2021). doi: https://doi.org/10.1164/rccm.202011-4055OC
Parekh A, Tolbert TM, Mooney AM, Ramos-Cejudo J, Osorio RS, Treml M, Herkenrath SD, Randerath WJ, Ayappa I, Rapoport DM. Endotyping Sleep Apnea One Breath at a Time: An Automated Approach for Separating Obstructive from Central Sleep Disordered Breathing. Am J Respir Crit Care Med. 2021 Aug 27; doi: 10.1164/rccm.202011-4055OC. Epub 2021 Aug 27. PMID: 34449303.
Copy Download .nbib Format: NLM
Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans.

Alzheimer's & dementia : the journal of the Alzheimer's Association

Zheng C, Fillmore NR, Ramos-Cejudo J, Brophy M, Osorio R, Gurney ME, Qiu WQ, Au R, Perry G, Dubreuil M, Chen SG, Qi X, Davis PB, Do N, Xu R.
PMID: 34569707
Alzheimers Dement. 2021 Sep 27; doi: 10.1002/alz.12465. Epub 2021 Sep 27.

INTRODUCTION: Tumor necrosis factor (TNF) inhibitors are widely used to treat rheumatoid arthritis (RA) and their potential to retard Alzheimer's disease (AD) progression has been reported. However, their long-term effects on the dementia/AD risk remain unknown.METHODS: A propensity scored...

Cite
Zheng C, Fillmore NR, Ramos-Cejudo J, et al. Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans. Alzheimers Dement. 2021;doi: 10.1002/alz.12465.
Zheng, C., Fillmore, N. R., Ramos-Cejudo, J., Brophy, M., Osorio, R., Gurney, M. E., Qiu, W. Q., Au, R., Perry, G., Dubreuil, M., Chen, S. G., Qi, X., Davis, P. B., Do, N., & Xu, R. (2021). Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans. Alzheimer's & dementia : the journal of the Alzheimer's Association, . https://doi.org/10.1002/alz.12465
Zheng, Chunlei, et al. "Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans." Alzheimer's & dementia : the journal of the Alzheimer's Association vol. (2021). doi: https://doi.org/10.1002/alz.12465
Zheng C, Fillmore NR, Ramos-Cejudo J, Brophy M, Osorio R, Gurney ME, Qiu WQ, Au R, Perry G, Dubreuil M, Chen SG, Qi X, Davis PB, Do N, Xu R. Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans. Alzheimers Dement. 2021 Sep 27; doi: 10.1002/alz.12465. Epub 2021 Sep 27. PMID: 34569707.
Copy Download .nbib Format: NLM
The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study.

Frontiers in aging neuroscience

Ramos-Cejudo J, Johnson AD, Beiser A, Seshadri S, Salinas J, Berger JS, Fillmore NR, Do N, Zheng C, Kovbasyuk Z, Ardekani BA, Bubu OM, Parekh A, Convit A, Betensky RA, Wisniewski TM, Osorio RS.
PMID: 34916927
Front Aging Neurosci. 2021 Nov 30;13:773984. doi: 10.3389/fnagi.2021.773984. eCollection 2021.

No abstract available.

Cite
Ramos-Cejudo J, Johnson AD, Beiser A, et al. The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study. Front Aging Neurosci. 2021;13:773984doi: 10.3389/fnagi.2021.773984.
Ramos-Cejudo, J., Johnson, A. D., Beiser, A., Seshadri, S., Salinas, J., Berger, J. S., Fillmore, N. R., Do, N., Zheng, C., Kovbasyuk, Z., Ardekani, B. A., Bubu, O. M., Parekh, A., Convit, A., Betensky, R. A., Wisniewski, T. M., & Osorio, R. S. (2021). The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study. Frontiers in aging neuroscience, 13773984. https://doi.org/10.3389/fnagi.2021.773984
Ramos-Cejudo, Jaime, et al. "The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study." Frontiers in aging neuroscience vol. 13 (2021): 773984. doi: https://doi.org/10.3389/fnagi.2021.773984
Ramos-Cejudo J, Johnson AD, Beiser A, Seshadri S, Salinas J, Berger JS, Fillmore NR, Do N, Zheng C, Kovbasyuk Z, Ardekani BA, Bubu OM, Parekh A, Convit A, Betensky RA, Wisniewski TM, Osorio RS. The Neutrophil to Lymphocyte Ratio Is Associated With the Risk of Subsequent Dementia in the Framingham Heart Study. Front Aging Neurosci. 2021 Nov 30;13:773984. doi: 10.3389/fnagi.2021.773984. eCollection 2021. PMID: 34916927; PMCID: PMC8670436.
Copy Download .nbib Format: NLM
Survival Analysis in Cognitively Normal Subjects and in Patients with Mild Cognitive Impairment Using a Proportional Hazards Model with Extreme Gradient Boosting Regression.

Journal of Alzheimer's disease : JAD

Khajehpiri B, Moghaddam HA, Forouzanfar M, Lashgari R, Ramos-Cejudo J, Osorio RS, Ardekani BA.
PMID: 34864679
J Alzheimers Dis. 2021 Dec 02; doi: 10.3233/JAD-215266. Epub 2021 Dec 02.

BACKGROUND: Evaluating the risk of Alzheimer's disease (AD) in cognitively normal (CN) and patients with mild cognitive impairment (MCI) is extremely important. While MCI-to-AD progression risk has been studied extensively, few studies estimate CN-to-MCI conversion risk. The Cox proportional...

Cite
Khajehpiri B, Moghaddam HA, Forouzanfar M, et al. Survival Analysis in Cognitively Normal Subjects and in Patients with Mild Cognitive Impairment Using a Proportional Hazards Model with Extreme Gradient Boosting Regression. J Alzheimers Dis. 2021;doi: 10.3233/JAD-215266.
Khajehpiri, B., Moghaddam, H. A., Forouzanfar, M., Lashgari, R., Ramos-Cejudo, J., Osorio, R. S., Ardekani, B. A. (2021). Survival Analysis in Cognitively Normal Subjects and in Patients with Mild Cognitive Impairment Using a Proportional Hazards Model with Extreme Gradient Boosting Regression. Journal of Alzheimer's disease : JAD, . https://doi.org/10.3233/JAD-215266
Khajehpiri, Boshra, et al. "Survival Analysis in Cognitively Normal Subjects and in Patients with Mild Cognitive Impairment Using a Proportional Hazards Model with Extreme Gradient Boosting Regression." Journal of Alzheimer's disease : JAD vol. (2021). doi: https://doi.org/10.3233/JAD-215266
Khajehpiri B, Moghaddam HA, Forouzanfar M, Lashgari R, Ramos-Cejudo J, Osorio RS, Ardekani BA. Survival Analysis in Cognitively Normal Subjects and in Patients with Mild Cognitive Impairment Using a Proportional Hazards Model with Extreme Gradient Boosting Regression. J Alzheimers Dis. 2021 Dec 02; doi: 10.3233/JAD-215266. Epub 2021 Dec 02. PMID: 34864679.
Copy Download .nbib Format: NLM
Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease.

Alzheimer's & dementia (Amsterdam, Netherlands)

Fossati S, Ramos Cejudo J, Debure L, Pirraglia E, Sone JY, Li Y, Chen J, Butler T, Zetterberg H, Blennow K, de Leon MJ.
PMID: 31334328
Alzheimers Dement (Amst). 2019 Jun 28;11:483-492. doi: 10.1016/j.dadm.2019.05.001. eCollection 2019 Dec.

INTRODUCTION: Plasma tau may be an accessible biomarker for Alzheimer's disease (AD), but the correlation between plasma and cerebrospinal fluid (CSF) tau and the value of combining plasma tau with CSF tau and phospho-tau (P-tau) are still unclear.METHODS: Plasma-tau,...

Cite
Fossati S, Ramos Cejudo J, Debure L, et al. Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease. Alzheimers Dement (Amst). 2019;11:483-492doi: 10.1016/j.dadm.2019.05.001.
Fossati, S., Ramos Cejudo, J., Debure, L., Pirraglia, E., Sone, J. Y., Li, Y., Chen, J., Butler, T., Zetterberg, H., Blennow, K., & de Leon, M. J. (2019). Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease. Alzheimer's & dementia (Amsterdam, Netherlands), 11483-492. https://doi.org/10.1016/j.dadm.2019.05.001
Fossati, Silvia, et al. "Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 11 (2019): 483-492. doi: https://doi.org/10.1016/j.dadm.2019.05.001
Fossati S, Ramos Cejudo J, Debure L, Pirraglia E, Sone JY, Li Y, Chen J, Butler T, Zetterberg H, Blennow K, de Leon MJ. Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease. Alzheimers Dement (Amst). 2019 Jun 28;11:483-492. doi: 10.1016/j.dadm.2019.05.001. eCollection 2019 Dec. PMID: 31334328; PMCID: PMC6624242.
Copy Download .nbib Format: NLM
Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans.

Alzheimer's & dementia : the journal of the Alzheimer's Association

Zheng C, Fillmore NR, Ramos-Cejudo J, Brophy M, Osorio R, Gurney ME, Qiu WQ, Au R, Perry G, Dubreuil M, Chen SG, Qi X, Davis PB, Do N, Xu R.
PMID: 34569707
Alzheimers Dement. 2021 Sep 27; doi: 10.1002/alz.12465. Epub 2021 Sep 27.

INTRODUCTION: Tumor necrosis factor (TNF) inhibitors are widely used to treat rheumatoid arthritis (RA) and their potential to retard Alzheimer's disease (AD) progression has been reported. However, their long-term effects on the dementia/AD risk remain unknown.METHODS: A propensity scored...

Cite
Zheng C, Fillmore NR, Ramos-Cejudo J, et al. Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans. Alzheimers Dement. 2021;doi: 10.1002/alz.12465.
Zheng, C., Fillmore, N. R., Ramos-Cejudo, J., Brophy, M., Osorio, R., Gurney, M. E., Qiu, W. Q., Au, R., Perry, G., Dubreuil, M., Chen, S. G., Qi, X., Davis, P. B., Do, N., & Xu, R. (2021). Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans. Alzheimer's & dementia : the journal of the Alzheimer's Association, . https://doi.org/10.1002/alz.12465
Zheng, Chunlei, et al. "Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans." Alzheimer's & dementia : the journal of the Alzheimer's Association vol. (2021). doi: https://doi.org/10.1002/alz.12465
Zheng C, Fillmore NR, Ramos-Cejudo J, Brophy M, Osorio R, Gurney ME, Qiu WQ, Au R, Perry G, Dubreuil M, Chen SG, Qi X, Davis PB, Do N, Xu R. Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans. Alzheimers Dement. 2021 Sep 27; doi: 10.1002/alz.12465. Epub 2021 Sep 27. PMID: 34569707.
Copy Download .nbib Format: NLM
Testing the impaired disengagement hypothesis: The role of attentional control and positive metacognitive beliefs in depression.

Behaviour research and therapy

Salguero JM, Ramos-Cejudo J, García-Sancho E, Arbulu I, Zaccagnini JL, Bjureberg J, Gross JJ.
PMID: 34543923
Behav Res Ther. 2021 Nov;146:103961. doi: 10.1016/j.brat.2021.103961. Epub 2021 Sep 08.

The impaired disengagement hypothesis holds that people ruminate - and thus increase their risk for depression - due to impaired attentional control and conflict signaling. We tested this hypothesis by examining the role of attentional control and conflict signaling...

Cite
Salguero JM, Ramos-Cejudo J, García-Sancho E, et al. Testing the impaired disengagement hypothesis: The role of attentional control and positive metacognitive beliefs in depression. Behav Res Ther. 2021;146:103961doi: 10.1016/j.brat.2021.103961.
Salguero, J. M., Ramos-Cejudo, J., García-Sancho, E., Arbulu, I., Zaccagnini, J. L., Bjureberg, J., & Gross, J. J. (2021). Testing the impaired disengagement hypothesis: The role of attentional control and positive metacognitive beliefs in depression. Behaviour research and therapy, 146103961. https://doi.org/10.1016/j.brat.2021.103961
Salguero, José M, et al. "Testing the impaired disengagement hypothesis: The role of attentional control and positive metacognitive beliefs in depression." Behaviour research and therapy vol. 146 (2021): 103961. doi: https://doi.org/10.1016/j.brat.2021.103961
Salguero JM, Ramos-Cejudo J, García-Sancho E, Arbulu I, Zaccagnini JL, Bjureberg J, Gross JJ. Testing the impaired disengagement hypothesis: The role of attentional control and positive metacognitive beliefs in depression. Behav Res Ther. 2021 Nov;146:103961. doi: 10.1016/j.brat.2021.103961. Epub 2021 Sep 08. PMID: 34543923.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries